All Stories

  1. Effectiveness of Distant/Remote Blessing Treatment on Cognitive-motor Function: A Randomized Double-blind Placebo-controlled Trial
  2. Exploring the Therapeutic Potentials of Nonpharmacological Blessing Energy Intervention for the Benefits of Psycho-Mental Impaired Individuals: A Clinical Trial
  3. Assessment of cognitive–motor functions in adults with perceived neuropsychological problems using NIH toolbox after remote biofield energy treatment as non‐pharmacological intervention: A randomized double‐blind placebo controlled trial
  4. Effects of distant biofield energy healing on adults associated with psychological and mental health-related symptoms: a randomized, placebo-controlled, double-blind study
  5. The use of biofield energy therapy as complementary and alternative medicine in human health care system: a narrative review and potential mechanisms
  6. Cannabidiol (CBD) Upregulates Vitamin D3 Receptors (VDRs) Expression That Modulates Cytokines (TNF-α, IL-6), Tissue Elasticity, Cellular Senescence, and Mitochondrial ATP Generation in Human and Rodent Cell Lines
  7. Vitamin D3 Supplementation: Improving Memory, Muscle Function, and Pain in Deficient Rats
  8. Simultaneous identification and quantification of pentacyclic triterpenoids and phenolic compounds from the leaves of Boswellia serrata using LC–MS/MS tandem mass spectrometry
  9. The role of biofield energy treatment on psychological symptoms, mental health disorders, and stress‐related quality of life in adult subjects: A randomized controlled clinical trial
  10. Efficacy of a novel proprietary dietary supplement (TRI 360TM) on psychological symptoms and stress-related quality of life in adult subjects: A randomized controlled clinical trial
  11. Impact on Fundamental Physiological Functional Biomarkers after Administration of Biofield Treated Formulation in Unpredictable Chronic Stress (UCS)-Induced Rats
  12. Evaluation of Anti-inflammatory Activity after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  13. Evaluation of Inflammatory Serum Cytokines after Treatment with the Consciousness Energy Healing Based Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley...
  14. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Brain Tissues in Cecal Slurry, LPS and E. Coli-Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  15. Evaluation of Cardiac Performance after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  16. Evaluation of Antioxidative Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  17. Elasticity Profile of Skin, Neuronal, Cardiac, and Skeletal Muscle Cells after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation
  18. Oxidative Stress and Inflammatory Biomarkers Analysis of Biofield Treated Proprietary Test Formulation in Heart Tissues in Cecal Slurry, LPS and E. Coli-induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  19. Anti-Inflammatory Activity of Biofield Energy Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  20. Evaluation of Immunomodulatory Effect of a Novel Test Formulation in D-Galactose-Induced Aging Dysfunction in Sprague Dawley Rats
  21. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Intestinal Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  22. Evaluation of Renal and Cardioprotective Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  23. LC-MS and GC-MS-Based Assessment of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios of Sulfamethoxazole
  24. Structural Characterization and Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Ofloxacin
  25. Effect of Biofield Treatment on Blood, Hepatic, and Cardiac Biomarkers in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  26. Characterization of the Consciousness Energy Healing Treated Cholecalciferol Using LC-MS and GC-MS Spectrometry
  27. Study of the Consciousness Energy Healing Treatment and It’s Effect on the Isotopic Abundance Ratio of Ascorbic Acid (Vitamin C)
  28. Evaluation of the Isotopic Abundance Ratio of Consciousness Energy Healing Treated L-Tryptophan Using LC-MS Spectrometry
  29. Effect of Consciousness Energy Healing Treatment on the Metal Profile and Properties of Tellurium
  30. Antioxidant Activity of Biofield Treated Proprietary Test Formulation Supplemented with Vitamins and Minerals in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  31. Evaluation of Vitamin D3 metabolite (25-OH Vit D3), Neurotransmitter (ACh), and the Expression of Proinflammatory Cytokines (IL-6 and TNF-α) in Tissue Homogenate after Administration of Biofield Energy Healing-based Novel Proprietary Test Formulation a...
  32. Liquid Chromatography-Mass Spectrometry Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated L-Cysteine
  33. "A Comprehensive Study of Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Berberine Chloride Using LC-MS and GC-MS"
  34. sotopic Abundance Ratio Evaluation of the Consciousness Energy Treated Pyridoxine Using LC-MS and GC-MS Spectrometry
  35. "Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid"
  36. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of L-Cysteine Using LC-MS Spectrometry
  37. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid Using LC-MS Spectrometry
  38. Influence of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  39. Impact of Biofield Energy Healing Treatment on the Isotopic Abundance Ratio Analysis of Pyridoxine HCl Using LC-MS and GC-MS Spectrometry
  40. Identification of Endothelin-1 and Nitric Oxide Activity in Aorta, Lung and Kidney after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-Name and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  41. Evaluation of Inflammatory Response after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  42. Neuroprotective (iNOS), fibrinolytic (FDP) Markers Analysis of Biofield Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  43. Evaluation of Inflammatory Serum Biomarkers after Treatment with the Consciousness Energy Healing-Based Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  44. Study of VDR Expression after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation Using Cellular Models
  45. Estimation of Sex Hormone, Blood Profiling, and Histopathological Analysis after Treatment with the Biofield Energy Treated Proprietary Test Formulation in Unpredictable Chronic Stress (UCS)- Induced Sprague Dawley Rats
  46. Study of Behavioral Parameters in Vitamin D3 Deficiency Diet (VDD) Induced Animal Model: An Influence of Biofield Energy Healing Treatment
  47. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  48. The LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Silver Sulfadiazine
  49. Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry
  50. Evaluation of Cardiac Biomarkers after Administration of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  51. Evaluation of Stress Biomakers (Cytokines) in Presence of Unpredictable Chronic Stress (UCS) in Sprague Dawley Rats after Treatment with the Biofield Energy Treated Novel Proprietary Test Formulation
  52. The Isotopic Abundance Ratio of Consciousness Energy Treated L-Tryptophan Using LC-MS Spectrometry
  53. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Lungs Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  54. LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of Consciousness Energy Healing Treated Ofloxacin
  55. Analysis of Isotopic Abundance Ratio of Consciousness Energy Healing Treated Metronidazole Using LC-MS and GC-MS Spectrometry
  56. Assessment of Neurobehavioral and Anti-Aging Effect of the Test Formulation in D-Galactose-Induced aging Dysfunction in Sprague Dawley Rats
  57. Prevention of Aging and Improvement of Longevity and Life-Span in D-Galactose Induced Aging Rats After Treatment with the Biofield Energy Per Se and Biofield Treated Proprietary Test Formulation
  58. Gas Chromatography and Mass Spectroscopy (GC-MS) Based Isotopic Abundance Ratio Evaluation of the Biofield Energy Treated Metronidazole
  59. Effect of the Biofield Energy Treated Proprietary Test Formulation for Sleep Biomarkers in the Unpredictable Chronic Stress (UCS) Animal Model
  60. Antiaging, Cognition and Anti-Inflammatory Potential of the Biofield Energy Treatment in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  61. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Cefazolin Sodium Using LC-MS and GC-MS Spectrometry
  62. Improvement of Vitamin D 3 Metabolites Level after Oral Administration of the Biofield Energy Treated Proprietary Test Formulation in Vitamin D 3 Deficiency Diet (VDD) Induced Rat Model
  63. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios (PM+1/PM and PM+2/PM) of Ofloxacin
  64. Influence of Consciousness Energy Healing Treatment on the Properties of Polylactic-co- Glycolic Acid (PLGA)
  65. Characterization of the biofield energy treated aluminium using PSA, PXRD, and TGA/DTG analytical techniques
  66. Consciousness Energy Healing Treatment Influenced the Physicochemical Properties of Zinc
  67. "Evaluation of Physicochemical and Thermal Properties of the Consciousness Energy Healing Treated Tellurium"
  68. In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
  69. Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
  70. Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
  71. Antioxidant and Organ Protective Potential of the Consciousness Energy Healing-Based Novel Test Formulation Using Different Biomarkers Analysis
  72. "Assessment of the Biofield Energy Healing Based Test Formulation on Human Organ Health Specific Biomarkers In Vitro Assays"
  73. Powder X-ray Diffraction and Particle Size Analysis of the Consciousness Energy Healing Treated Vanadium Pentoxide (V2O5)
  74. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Zinc
  75. Consciousness Energy Healing Treatment: Physicochemical and Thermal Characterization of Magnesium
  76. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Properties of Pyridoxine HCl
  77. Complementary and Alternative Medicine: Impact of Consciousness Healing Treatment on the Characteristic Properties of Sulfamethoxazole
  78. Physicochemical and Thermal Characterization of Ascorbic Acid: Impact of Biofield Energy Treatment
  79. Physicochemical and Thermal Characterization of the Consciousness Energy Healing Treated Folic acid
  80. In Vitro Effect of Biofield Energy Treated DMEM On Mitochondrial Biogenesis Using Myoblasts Cell Line, C2C12
  81. Evaluation of Stress Biomarkers after Oral Administration of the Consciousness Energy Healing Treated Novel Herbomineral Formulation in Male Sprague Dawley Rats
  82. Solid State Characterization of the Consciousness Energy Healing Treated Magnesium
  83. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Cefazolin Sodium
  84. Complementary and Alternative Medicine: Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Treated Metronidazole
  85. Solid State Characterization for a Comparative Evaluation of the Biofield Energy Treated and Un-treated Ascorbic Acid
  86. Evaluation of the Physicochemical and Thermal Properties of Folic Acid: Influence of the Energy of Consciousness Healing Treatment
  87. Flutamide: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Characteristics
  88. Complementary and Alternative Medicine: Evaluation of the impact of Biofield Energy Treatment on L-Cysteine
  89. Spectroscopic and Calorimetric Evaluation of the Biofield Energy Healing Treated Ofloxacin
  90. Effect of the Consciousness Energy Healing Treatment on the Characteristic Properties of Cefazolin Sodium
  91. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Cholecalciferol (Vitamin D3)
  92. Biofield Energy Treatment: Physicochemical and Thermal Characterization of L-Tryptophan
  93. Consciousness Energy Healing Treatment: Spectroscopic and Calorimetric Evaluation of the Biofield Energy Treated Hydroxypropyl β-Cyclodextrin
  94. Assessment of Anti-Ageing Potential of Consciousness Energy Healing Treated DMEM and HFF-1 Cells using Cellular Proliferation and Collagen Metabolism Assays
  95. Characterization of the Physicochemical and Thermal properties of the Biofield Energy Treated Flutamide Using PSA, PXRD, TGA/DTG, and DSC Analytical Techniques
  96. Particle Size, Surface Area, Crystallite Size, and Thermal Analysis of Consciousness Energy Healing Treated Selenium
  97. Assessment of the Physicochemical and Thermal Characterization of Biofield Energy Treated Polylactic-co-glycolic acid (PLGA)
  98. Complementary and Alternative Medicine: Impact of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Withania somnifera Root Extract
  99. Biofield Energy Treatment Based Test Formulation as a Novel and Efficient Approach on Various Biomarkers in human Bones, Heart, Liver, Lungs, and Brain Cells
  100. Investigation of Vital Organ Specific Biomarkers Using CellBased Assays after Treatment with the Biofield Energy Treated Test Formulation
  101. Study of the Effect of Consciousness Energy Healing Treatment on the Natural Product Berberine Chloride
  102. Evaluation of the Outcome of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Magnesium
  103. Impact of the Trivedi Effect® on the Physicochemical Properties of Antimony
  104. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of an Anticancer Drug 6-Mercaptopurine
  105. Biofield Energy Therapy: Role in Multiple Organ Health Specific Biomarkers in Cell-Based Assay
  106. The Implication of Biofield Energy Treated DMEM on Bone‐Health Assessment Using Osteoblast Cells
  107. Evaluation of the Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  108. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Silver Sulfadiazine
  109. Wound Healing Activity of Consciousness Energy Healing Treatmenton HFF-1 Cells and DMEM Using Scratch Assay
  110. Evaluation of the Consciousness Energy Healing Treated Berberine Chloride Using PXRD, PSA, and DSC Analysis
  111. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of 6-Mercaptopurine
  112. The Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Silver Oxide (Ag2O)a
  113. Evaluation of Phosphodiesterase-5 Inhibitory Potential of Biofield Energy Treated DMEM by Determining cGMP Level in Human Endothelial Cell Line
  114. Influence of the Biofield Energy Therapy on the Physicochemical and Thermal Properties of Sulfamethoxazole
  115. Assessment of the Influence of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Lead Using PXRD, PSA, and DSC
  116. Evaluation of the Physicochemical and Thermal Properties of Chromium Trioxide (CrO3): Impact of Consciousness Energy Healing Treatment
  117. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Characteristics of Folic Acid
  118. Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  119. An Investigation of the Consciousness Energy Healing Therapy on Physicochemical and Thermal Properties of Silver Sulfadiazine
  120. Antioxidative Potential of Consciousness Energy Healing Treatment on HepG2 Cells and DMEM after Oxidative Stress Induced by Hydrogen Peroxide
  121. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  122. Effect of the Consciousness Energy Healing Treatment on DMEM for the Proliferation and Differentiation of Human Bone Osteosarcoma Cells to Improve Bone Health
  123. Antiaging Potentia
  124. Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Healing Treated Ofloxacin
  125. Antiaging Potential of Consciousness Energy Healing-Based Novel Proprietary Formulation
  126. Role of Vitamin D3 on Bone Health in Human Bone Osteosarcoma Cells (MG-63): Influence of Biofield Energy Healing Treatment
  127. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Vitamin D3 (Cholecalciferol)
  128. The Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of L-Cysteine
  129. The Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of 6-Mercaptopurine
  130. Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  131. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Lead Using PXRD, PSA, and DSC Analysis
  132. Assessment of Biofield Energy Healing Based Vitamin D3 Effects on Bone Health Parameters
  133. Biofield Energy Treated Vitamin D3 on the Structural Crosslinks, Maturation, and Bone Mineralization
  134. Assessment of Energy of Consciousness Healing on Cell Growth of Plant Stem Cells Callus Culture
  135. "A Comparative Analysis of Vitamin D3 and Biofield Energy Treated Vitamin D3 in Bone Health Using MG-63 Cell Line"
  136. Increase in Bone Mass Density and Overall Bone Health Following High-Impact of Bio-field Energy Treated Vitamin D3inMG-63 Cell Line
  137. Biofield Energy Enriched Vitamin D3 versus Vitamin D3 in Preventing Fractures and Bone Loss
  138. Functional Modification of Bone Tissues After Treatment with the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  139. Role of Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63): A Multidisciplinary Aspect on Bone Health
  140. Vitamin D3 and Consciousness Energy Healing TreatmentModality on Human Osteoblast Cells
  141. The Bone Regenerative Effects of the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  142. Biofield Energy Healing Based Vitamin D3: An Improved Overall Bone Health Activity in MG-63 Cell Line
  143. Influence of the Biofield Energy Treated Vitamin D<sub>3</sub> on Human Osteoblast-Like Cells
  144. Effect of Biofield EnergyTreated Vitamin D3 on the Proliferation of Osteoblast-Like MG-63 Human Osteosarcoma Cells in vitro
  145. Biofield Energy Based Vitamin D<sub>3</sub> Stimulates <i>In vitro</i> Osteoblasts Differentiation in MG-63 Cell line
  146. An <i>In vitro</i> Experiment on Bone Growth and Differentiation in Human Bone Osteosarcoma Cells (MG-63): Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  147. Assessment of Bone Health After Treatment with the Consciousness Energy Healing Treated Vitamin D<sub>3</sub> in Human Bone Osteosarcoma Cells (MG-63)
  148. Biofield Energy Enriched Vitamin D<sub>3</sub>: A New Horizons for Development of Bone Health Using MG-63 Cells
  149. Regulation of Bone Health Parameters After Treatment with Biofield Energy Healing Based Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63)
  150. <i>In vitro</i> Study on Human Bone Osteosarcoma Cells (MG-63): Role of Biofield Energy Treated Vitamin D<sub>3</sub>
  151. Biofield Energy Treated Vitamin D<sub>3</sub>: Therapeutic Implication on Bone Health Using Osteoblasts Cells
  152. The Influence of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health and Its Health Consequences in MG-63 Cell-Line
  153. Effect of Biofield Energized Vitamin D<sub>3</sub> on Bone Health in MG-63 Cell-Line
  154. Regulation of Bone Health Parameters in MG-63 Cell Line After Treatment with Biofield Energy Treated Vitamin D<sub>3</sub>
  155. The Effect of Vitamin D<sub>3</sub> on Bone Mineralization: Influence of Consciousness Energy Healing Treatment
  156. Evaluation of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health Parameters in Human Bone Osteosarcoma Cells (MG-63)
  157. Influence of Biofield Treated Vitamin D<sub>3</sub> on Proliferation, Differentiation, and Maturation of Bone-Related Parameters in MG-63 Cell-Line
  158. A Perspective of Bone Health Study: Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  159. Influenced of Biofield Energy Healing Treatment on Vitamin D<sub>3</sub> for the Assessment of Bone Health Parameters in MG-63 cells
  160. Evaluation of Biofield Energy Treated Vitamin D<sup>3</sup> in Human Osteoblasts Cells
  161. Exploring the Effects of Biofield Energy Treated Vitamin D<sup>3</sup> on Bone Health Parameters in MG-63 Cell Line
  162. The Potential Benefits of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Mineralization in Human Bone Osteosarcoma Cells (MG-63)
  163. Improved Metabolism of Vitamin D<sub>3</sub> in Human Osteoblasts Cells After Biofield Energy Healing Treatment
  164. An Alternative Approach for the Management of Bone Health: Role of Biofield Energy Healing Treated Vitamin D<sub>3</sub>
  165. Effects of Vitamin D<sub>3</sub> on the Proliferation and Mineralization of Human Osteoblast-Like Cells: Implications of Biofield Energy Healing Treatment
  166. Impact of Biofield Energy Healing Treated Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63) for Bone Health
  167. Role of Vitamin D<sub>3</sub> on Alkaline Phosphatase, Collagen, and Bone Mineralization: Impact of Biofield Energy Healing Treatment
  168. Biofield Energy Treated Vitamin D<sub>3</sub>: Direct Effect on Bone Health Using Human Osteoblast-Like Cells
  169. <i>In Vitro</i> Effects of Biofield Energy Treated Vitamin D<sub>3</sub> Supplementation on Bone Formation by Osteoblasts Cells
  170. Energy of Consciousness Healing on Growth and Yield of the Plant Stem Cells Culture
  171. Evaluation of the Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of Flutamide
  172. Influence of the Biofield Energy Healing Treatment on the Physicochemical and Thermal Properties of Metronidazole
  173. Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Hydroxypropyl -Cyclodextrin
  174. Evaluation of the Effect ofBiofield Energy Treatment on Physicochemical and Thermal Properties of Hydroxypropyl β-Cyclodextrin
  175. Anti-Oxidative Potential of Biofield Energy Treatment on Lung Health Using A549 Cells
  176. Effect of Biofield Energy Treatment on Bone Cell Proliferation and Differentiation for the Assessment of its Potential to Improve Bone Health
  177. Physicochemical and Spectroscopic Characterization of Biofield TreatedButylated Hydroxytoluene
  178. Effect of Biofield Energy Treated Cell Growth Medium on Human Fibroblast Cell Growth for Assessment of Skin Health Promotion Potential
  179. Evaluation of Bone Mineral Density and Biochemical Parameters of Bone Metabolism after Treatment with Biofield Energy Treated Vitamin D3 in MG-63 Cells
  180. An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line
  181. Spectral, and Thermal Properties of Sodium Selenate Treated with the Energy of Consciousness
  182. Consciousness Healing Treatment on the Physical, Structural, and Thermal Properties of Zinc Chloride
  183. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  184. Energy Healing Treatment on the Physical, Spectral, and Thermal Properties of Zinc Chloride
  185. Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  186. Structure and Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  187. Withania somnifera (Ashwagandha) Root Extract Treated with the Energy of Consciousness
  188. Properties of Sodium Selenate Treated with the Energy of Consciousness (The Trivedi Effect®)
  189. Properties and Isotopic Abundance Ratio of Biofield Energy Treated Magnesium Gluconate
  190. Evaluation of Isotopic Abundance Ratio and Structural Properties of Magnesium Gluconate
  191. Evaluation of Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  192. Evaluation of the Energy of Consciousness Healing Treated Withania somnifera Root Extract
  193. Magnesium Gluconate Treated with the Energy of Consciousness Using LC-MS and NMR Spectroscopy
  194. Withania Somnifera (Ashwagandha) Root Extract Using LC-MS, GC-MS, and NMR Spectroscopy
  195. Physical, Spectroscopic, Thermal and Behavioral Properties of Ashwagandha Root Extract
  196. Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  197. Consciousness Energy Healing Treatment on Withania somnifera Root Extract
  198. Evaluation of the Physicochemical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  199. Evaluation of Skin Protective Effect Using in Vitro Cell Line Models of Biofield
  200. Skin Nourishing Effects of Biofield Energy Healing Treatment Based Herbomineral Formulation
  201. Skin Protective Activity of Consciousness Energy Healing Treatment Based Herbomineral Formulation
  202. The Study of Biofield Energy Treatment Based Herbomineral Formulation in Skin Health and Function
  203. Use of Consciousness Energy Healing Based Herbomineral Formulation for Skin Anti-Aging Strategies
  204. Overall Skin Health Potential of the Biofield Energy Healing Based Herbomineral Formulation
  205. Energy Healing Treatment on Herbomineral Formulation in Different Skin Health Parameters
  206. Biofield Energy Healing Based Herbomineral Formulation: An Emerging Frontier in Cosmetic Medicine
  207. Thermal and Behavioral Properties of the Biofield Energy Healing Treated Sodium Selenate
  208. Physicochemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  209. Structural Characterization and Isotopic Abundance Ratio Analysis of Magnesium Gluconate
  210. Healing Treatment on Physical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  211. Consciousness Healing Treated Withania Somnifera Root Extract Using LC-MS, GC-MS, and NMR
  212. Withania somnifera Root Extract Using GC-MS and Nuclear Magnetic Resonance Spectroscopy
  213. Physicochemical, Thermal, Structural, and Behavioral Properties Analysis in Magnesium Gluconate
  214. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  215. Solid State Characterization of Withania somnifera (Ashwagandha) Root Extract
  216. Energy Healing Treatment Based Herbomineral Formulation Against Various Skin Health Parameters
  217. The Use of Novel and Unique Biofield Energy Healing Treatment for the Improvement of Poorly Bioavailable Compound, Berberine in Male <i>Sprague Dawley</i> Rats
  218. The Influence of Energy of Consciousness Healing Treatment on Low Bioavailable Resveratrol in Male Sprague Dawley Rats
  219. Skin Photo-Protective and Anti-ageing Activity of Consciousness Energy Healing Treatment
  220. Immunomodulatory Response of Herbomineral Formulation in Male Sprague Dawley Rats
  221. Novel Herbomineral Formulation After Oral Administration in Male Sprague Dawley Rats
  222. Characterization of the Consciousness Energy Healing Treated Withania somnifera Root Extract
  223. Analysis of Withania somnifera Root Extract After Treatment with the Energy of Consciousness
  224. Differential Regulation of Immune Biomarkers by the The Trivedi Effect® on Herbomineral Formulation
  225. Immunopotentiating Impact of The Trivedi Effect® on Herbomineral Formulation Oral Administration
  226. Evaluation of the Physico-chemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  227. Impact of Trivedi Effect® on Physicochemical, Thermal, Properties of Magnesium Gluconate
  228. Evaluation of Immunomodulatory Properties After Oral Administration of Biofield Energy Treated Test Formulation in <i>Sprague Dawley</i> Rats: Influence of the Trivedi Effect<sup>®</sup>
  229. Evaluation of the Effects of Biofield Energy Healing Based Herbomineral Formulation on Various Biomarkers in Male <i>Sprague Dawley</i> Rats: Potential Role of the Trivedi Effect<sup>®</sup>
  230. Characterization of Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate After Treatment with the Energy of Consciousness
  231. Evaluation of Immune Biomarkers After Oral Administration of the Novel Herbomineral Formulation Treated with The Trivedi Effect<sup>®</sup> - Biofield Energy Healing in Male <i>Sprague Dawley</i> Rats
  232. Immunomodulatory Activity of Biofield Energy Healing Based Herbomineral Formulation in <i>Sprague Dawley</i> Rats: Evidence for Humoral and Cell-Mediated Responses
  233. An Investigation of The Trivedi Effect<sup>®</sup>-Energy of Consciousness Healing Treatment to Modulate the Immunomodulatory Effect of Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  234. Assessment of Consciousness Energy Healing Treatment on Immune Biomarkers After Oral Administration of Herbomineral Formulation in <i>Sprague Dawley</i> Male Rats
  235. Evaluation of Immune Biomarkers After Oral Administration of Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  236. Evaluation of Immunomodulatory Parameters in Female <i>Sprague Dawley</i> Rats after Oral Administration of the Biofield Energy Healing Treated Herbomineral Formulation
  237. Impact of Biofield Treated Formulation on Immune Biomarkers of Female Sprague Dawley Rats
  238. Investigation of Immune Biomarkers Regulation by Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  239. Modulation of Immune Biomarkers by Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rat: Potential Role of Energy of Consciousness
  240. Effect of Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Novel Herbomineral Formulation on Immune Biomarkers After Oral Administration in Female <i>Sprague Dawley</i> Rats
  241. Immunomodulatory Potential of New Classical Herbomineral Formulation in Experimental Animals: Impact of Biofield Energy Healing Treatment
  242. Assessment of Immunomodulatory Activity of the Biofield Energy Treated Novel Herbomineral Formulation After Oral Administration in Female <i>Sprague Dawley</i> Rats
  243. Characterization of the Physicochemical, Structural, and Thermal Properties of Zinc Chloride After the Consciousness Energy Healing Treatment
  244. Implication of Biofield Energy Healing Based Vitamin D3 on Osteoblastic Differentiation
  245. Improved Bone Health Parameters After Treatment with Consciousness Energy Treated Vitamin D3
  246. A Study on the Effect of the Energy of Consciousness Healing Treatment on Physicochemical and Thermal Properties of Vitamin D<sub>3</sub> (Cholecalciferol)
  247. Evaluation of the Effect of the Energy of Consciousness Healing Treatment on Physicochemical and Thermal Properties of Pyridoxine Hydrochloride
  248. Assessment of Physicochemical and Thermal Properties of Energy of Consciousness Healing Treated Ferrous Sulphate Using PXRD, PSD, DSC, and TGA/DTG Analysis
  249. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Magnesium Gluconate
  250. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Treated Ortho-Toluic Acid
  251. Biochemical Reactions, and Genotypic Pattern of Biofield Treated Pseudomonas aeruginosa
  252. Thermal, Spectroscopic and Chemical Characterization of Biofield Energy Treated Anisole
  253. Biofield Energy Treated Nitrophenol Derivatives Using Gas Chromatography-Mass Spectrometry
  254. Physicochemical Characterization of Biofield Energy Treated Hi VegTM Acid Hydrolysate
  255. 1,2,3-Trimethoxybenzene (TMB) After Biofield Energy Treatment (The Trivedi Effect®) Using GC-MS
  256. Biofield Energy Treated Resorcinol Using Gas Chromatography-Mass Spectrometry Technique
  257. Isotopic Abundance of 2H, 13C, 18O, and 37Cl in Biofield Energy Treated Dichlorophenol Isomers
  258. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Indole Using GC-MS
  259. 13C/12C or 2H/1H and 18O/16O in Biofield Energy Treated 1-Chloro-3-Nitrobenzene (3-CNB) Using GC-MS
  260. Isotopic Abundance of 13C, 2H, and 18O in Biofield Energy Treated p-tertiary Butylphenol (PTBP)
  261. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Methyl-2-napthylether (Nerolin)
  262. Biofield Energy Treated 1,4-Dichlorobenzene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  263. Biofield Energy Healing (The Trivedi Effect®) Based Herbomineral Formulation in Mouse Splenocytes
  264. Evaluation Mouse Splenocytes After Co-Incubation with the Biofield Energy Treated Formulation
  265. Mouse Splenocyte Cells After Incubation with Biofield Energy Healing Based Herbomineral Formulation
  266. Impact of the Trivedi Effect Herbomineral Formulation on Pro-inflammatory Cytokines Expression
  267. Pro-Inflammatory Cytokines Expression in Murine Dendritic and Splenocyte Cells
  268. Mouse Splenocytes After Incubation with Biofield Treated Herbomineral Formulation
  269. Mouse Dendritic and Splenocyte Cells for Modulation of Pro-inflammatory Cytokines
  270. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Ammonium Acetate and Ammonium Chloride: An Impact of Biofield Treatment
  271. Characterization of Physical, Thermal and Structural Properties of Chromium (VI) Oxide Powder: Impact of Biofield Treatment
  272. Characterization of Physical, Spectral and Thermal Properties of Biofield Treated 1,2,4-Triazole
  273. Antibiogram Typing and Biochemical Characterization of Klebsiella pneumoniae after Biofield Treatment
  274. Physical, Thermal and Spectroscopic Characterization of m-Toluic Acid: an Impact of Biofield Treatment
  275. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Biofield Treated Salicylic Acid and Sparfloxacin
  276. Physical and Structural Characterization of Biofield Treated Imidazole Derivatives
  277. Evaluation of Physical, Thermal and Spectroscopic Properties of Biofield Treated p-Hydroxyacetophenone
  278. Characterization of Physico-Chemical and Spectroscopic Properties of Biofield Energy Treated 4-Bromoacetophenone
  279. Physicochemical and Spectroscopic Characterization of Biofield Treated Triphenyl Phosphate
  280. Physical and Structural Characterization of Biofield Energy Treated Carbazole
  281. Evaluation of Biofield Treatment on Atomic and Thermal Properties of Ethanol
  282. Characterisation of Physical, Spectral and Thermal Properties of Biofield treated Resorcinol
  283. Physicochemical and Atomic Characterization of Silver Powder after Biofield Treatment
  284. Spectroscopic Characterization of Disodium Hydrogen Orthophosphate and Sodium Nitrate after Biofield Treatment
  285. Characterization of Physical and Structural Properties of Aluminium Carbide Powder: Impact of Biofield Treatment
  286. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen
  287. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Methyl-2-Naphthyl Ether
  288. Antimicrobial Sensitivity, Biochemical Characteristics and Biotyping of Staphylococcus saprophyticus: An Impact of Biofield Energy Treatment
  289. Physical, Thermal and Spectral Properties of Biofield Treated 1,2,3-Trimethoxybenzene
  290. Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen
  291. Physical, Thermal and Spectroscopic Characterization of Biofield Treated p-Chloro-m-cresoln
  292. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2, 6-Diaminopyridine
  293. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated O-Aminophenol
  294. Characterization of Physicochemical and Thermal Properties of Chitosan and Sodium Alginate after Biofield Treatment
  295. Biofield Energy Treatment: A Potential Strategy for Modulating Physical, Thermal and Spectral Properties of 3-Chloro-4-fluoroaniline
  296. The Potential Impact of Biofield Energy Treatment on the Physical and Thermal Properties of Silver Oxide Powder
  297. Physical and Thermal Properties of O-Nitrophenol, M-Nitrophenol and P-Tertiary Butyl Phenol
  298. Antibiogram Pattern of Shigella flexneri: Effect of BioField Treatment
  299. Physical, Thermal and Spectral Properties of Biofield Energy Treated 2,4-Dihydroxybenzophenone
  300. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Energy Treated p-Phenylenediamine and p-Toluidine
  301. Characterization of Phenotype and Genotype of Biofield Treated Enterobacter aerogenes
  302. Evaluation of Antibiogram, Genotype and Phylogenetic Analysis of Biofield Treated Nocardia otitidis
  303. Potential Impact of BioField Treatment on Atomic and Physical Characteristics of Magnesium
  304. Evaluation of Thermal and Physical Properties of Magnesium Nitride Powder: Impact of Biofield Energy Treatment
  305. Influence of Biofield Treatment on Physical and Structural Characteristics of Barium Oxide and Zinc Sulfide
  306. Antibiogram and Genotypic Analysis using 16S rDNA after Biofield Treatment on Morganella morganii
  307. Investigation of Biofield Treatment on Antimicrobial Susceptibility, Biochemical Reaction Pattern and Biotyping of Enteropathogenic Multidrug-Resistant Escherichia coli Isolates
  308. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  309. Assessment of Antibiogram of Multidrug-Resistant Isolates of Enterobacter aerogenes after Biofield Energy Treatment
  310. Characterization of Biofield Energy Treated 3-Chloronitrobenzene: Physical, Thermal, and Spectroscopic Studies
  311. Impact of Biofield Energy Treatment on Soil Fertility
  312. Influence of Biofield Energy Treatment on Isotopic Abundance Ratio in Aniline Derivatives
  313. Studies on Physicochemical Properties of Biofield Treated 2,4-Dichlorophenol
  314. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Potato Micropropagation Medium
  315. Evaluation of Biofield Treated Peptone And Malmgren Modified Terrestrial Orchid Medium
  316. Physical, Thermal and Spectral Properties of Biofield Treated 3-Nitroacetophenone
  317. Thermal, Spectroscopic and Chromatographic Characterization of Biofield Energy Treated Benzophenone
  318. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2-Aminopyridine
  319. Characterization of Physical, Spectroscopic and Thermal Properties of Biofield Treated Biphenyl
  320. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2,6-Dichlorophenol
  321. Physicochemical and Spectral Characterization of Biofield Energy Treated 4-Methylbenzoic Acid
  322. Chromatographic, Spectroscopic, and Thermal Characterization of Biofield Energy Treated N,N-Dimethylformamide
  323. Physicochemical Characterization of Biofield Energy Treated Calcium Carbonate Powder
  324. Molecular Analysis of Biofield Treated Eggplant and Watermelon Crops
  325. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated p-Anisidine
  326. Characterization of Physical and Thermal Properties of Biofield Treated Neopentyl glycol
  327. Physical, Thermal and Spectral Parameters of Biofield Energy Treated Methylsulfonylmethane
  328. Antibiogram Typing of Biofield Treated Multidrug Resistant Strains of Staphylococcus Species
  329. Analysis of Physical, Thermal, and Structural Properties of Biofield Energy Treated Molybdenum Dioxide
  330. Physical and Structural Properties of Calcium Carbide and Praseodymium Oxide
  331. Physicochemical and Spectroscopic Characteristics of Biofield Treated p-Chlorobenzophenone
  332. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated Date Palm Callus Initiation Medium
  333. Biofield Energy Treatment on Physical and Thermal Characteristics of Selenium Powder
  334. Morphological Characterization, Quality, Yield & DNA Fingerprinting of Energy Treated Alphonso Mango
  335. Escherichia coli for Antimicrobial Susceptibility, Biochemical Reaction and Biotyping
  336. Evaluation of Isotopic Abundance Ratio in Naphthalene Derivatives After Biofield Energy Treatment
  337. Improved Susceptibility Pattern of Antimicrobials Using Vital Energy Treatment on Shigella sonnei
  338. Biochemical Differentiation & Molecular Characterization of Biofield Treated Vibrio parahaemolyticus
  339. Physical, Thermal and Spectroscopical Characterization of Biofield Treated Triphenylmethane: An Impact of Biofield Treatment
  340. Experimental Investigation on Physical, Thermal and Spectroscopic Properties of 2-Chlorobenzonitrile: Impact of Biofield Treatment
  341. Characterization of Biofield Energy Treated Murashige and Skoog Plant Cell Culture Media
  342. Physicochemical and Spectroscopic Characterization of Yeast Extract Powder After the Biofield Energy Treatment
  343. Physical, Spectroscopic and Thermal Characterization of Biofield Treated Fish Peptone
  344. Physicochemical and Spectroscopic Properties of Biofield Energy Treated Protose
  345. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated Gerbera Multiplication Medium
  346. Biofield Treated Phosphate Buffer Saline and Hanks Balanced Salt Medium
  347. Characterization of Physicochemical and Spectroscopic Properties of Biofield Energy Treated Bio Peptone
  348. Spectral and Thermal Properties of Biofield Energy Treated Cotton
  349. Effect of Biofield Treated Energized Water on the Growth and Health Status in Chicken
  350. Characterization of Atomic and Physical Properties of Biofield Energy Treated Manganese Sulfide Powder
  351. Assessment of Antibiogram of Biofield Energy Treated Serratia marcescens
  352. Biofield Treatment on Viral Load Against Human Immunodeficiency-1 and Cytomegalo Viruses
  353. Antibiogram, Biochemical Reactions and Biotyping of Biofield Treated Providencia rettgeri
  354. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using GC-MS
  355. Phenotyping and Genotyping Characterization of Proteus vulgaris After Biofield Treatment
  356. Plant Growth Regulator, Immunity and DNA Fingerprinting of Biofield Energy Treated Mustard Seeds
  357. Agronomic Characteristics, Growth Analysis, and Yield Response of Biofield Treated Mustard, Cowpea, Horse Gram, and Groundnuts
  358. Physical, Thermal and Spectroscopic Studies of Biofield Treated p-Chlorobenzonitrile
  359. Effect of Biofield Treatment on Physical, Thermal, and Spectral Properties of SFRE 199-1 Mammalian Cell Culture Medium
  360. Biochemical Marker – Glutathione and DNA Fingerprinting of Biofield Energy Treated Oryza sativa
  361. Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections
  362. Morphological and Molecular Analysis Using RAPD in Biofield Treated Sponge and Bitter Gourd
  363. Antibiogram, Biochemical Reactions and Genotyping Characterization of Biofield Treated <i>Staphylococcus aureus</i>
  364. Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives
  365. Vegetative Growth Parameters in Biofield Treated Bottle Gourd (Lagenaria siceraria) & Okra
  366. Genetic Diversity Using SSR Markers & Growth Regulator Response in Biofield Treated Cotton
  367. Ratio of 13C, 2H, and 18O in Biofield Energy Treated Ortho and Meta Toluic Acid Isomers
  368. Plant Growth, Yield and Yield Attributes of Biofield Energy Treated Mustard and Chick Pea Seeds
  369. Antimicrobial Susceptibility of Proteus mirabilis: Impact of Biofield Energy Treatment
  370. Bacterial Identification Using 16S rDNA Gene Sequencing and Antibiogram Analysis on Biofield Treated Pseudomonas fluorescens
  371. Impact of Biofield Treatment on Spectroscopic and Physicochemical Properties of p-Nitroaniline
  372. Physicochemical and Spectroscopic Characterization of p-Chlorobenzaldehyde: An Impact of Biofield Energy Treatment
  373. Evaluation of Atomic, Physical and Thermal Properties of Tellurium Powder: Impact of Biofield Energy Treatment
  374. Antibiogram of Multidrug-Resistant Isolates of Pseudomonas aeruginosa after Biofield Treatment
  375. Characterization of Antimicrobial Susceptibility Profile of Biofield Treated Multidrug-resistant Klebsiella oxytoca
  376. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii
  377. Antimicrobial Susceptibility, Biochemical Characterization and Molecular Typing of Biofield Treated Klebsiella pneumoniae
  378. Modification of Physical and Thermal Properties of Gluten Hydrolysate and Ipomoea Macroelements
  379. Investigation of Isotopic Abundance Ratio of Biofield Treated Phenol Derivatives Using Gas Chromatography-Mass Spectrometry
  380. Physical, Atomic and Thermal Properties of Biofield Treated Lithium Powder
  381. Potential Impact of Biofield Energy Treatment on the Atomic, Physical and Thermal Properties Indium Powder
  382. Physical, Spectroscopic and Thermal Characterization of Biofield treated Myristic acid
  383. Physical, Thermal and Spectroscopic Studies on Biofield Treated p-Dichlorobenzene
  384. Antimicrobial Susceptibility Pattern, Biochemical Characteristics and Biotyping of Salmonella paratyphi A: An Impact of Biofield Treatment
  385. Spectroscopic Characterization of Disulfiram and Nicotinic Acid after Biofield Treatment
  386. Biofield Treatment: A Potential Strategy for Modification of Physical and Thermal Properties of Indole
  387. In Vitro Evaluation of Antifungal Sensitivity Assay of Biofield Energy Treated Fungi